Pupillometry in Delayed Sleep Wake Phase Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorNorthwestern University

About this trial

The goal of this observational study is to characterize the pupil light response in patients with delayed sleep-wake phase disorder. A subset of participants will take part in a clinical trial to determine if increasing serotonin can alter the circadian response to light. The main questions it aims to answer is:

Are there differences in the light response in patients with delayed sleep-wake phase disorder? Does citalopram increase melatonin suppression in patients with delayed sleep-wake phase disorder?

Participants will complete activity and melatonin testing at home to determine their circadian timing. This will be followed by an eye test looking at the pupil response to different light stimuli. A subset of participants will complete two inpatient admissions where melatonin levels will be sampled and they will be exposed to a bright light. During one round of testing they will receive a placebo and in the other round of testing they will take a single dose of citalopram, a selective serotonin reuptake inhibitor.

Eligibility criteria

Qualifiers

Delayed sleep-wake phase disorder

Disqualifiers

Use of medications known to alter pupil diameter

History of eye disease or eye surgery

Unstable medical or psychiatric condition

Shift work or self imposed irregular sleep schedules

Trial design

Treatments tested in this trial

  • Light and Citalopram

Treatment groups

220 Participants
are divided into 1 treatment group

Sponsors and collaborators

Northwestern University

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator